BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Clinical trials for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
PET scans guide new combo therapy to fight returning prostate cancer
Disease control Recruiting nowThis study is for men whose prostate cancer has returned after surgery, shown by a rising PSA level. It tests whether adding a stronger drug combination (apalutamide plus abiraterone and prednisone) to standard radiation and hormone therapy can better control the cancer. For thos…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 03:32 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for men whose prostate cancer has returned or spread to a few spots after surgery. About 118 participants will receive o…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 03:30 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis study looks at whether giving radiation alone or with hormone therapy works better for men whose prostate cancer has returned and spread. It also tests if adding pelvic radiation helps stop further spread. About 532 men with recurrent, hormone-sensitive prostate cancer will …
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could home cancer care be just as safe and more satisfying for black men?
Symptom relief Recruiting nowThis study looks at whether giving cancer therapy at home instead of in a clinic can improve the experience for Black men with advanced prostate cancer. About 38 participants will try both home and clinic treatments to compare safety, side effects, and satisfaction. The goal is t…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 26, 2026 02:48 UTC